What Makes Medpace Holdings (MEDP) an Investment Choice?

1 week ago 11

Soumya Eswaran

Tue, December 9, 2025 astatine 8:00 AM CST 3 min read

Giverny Capital Asset Management, LLC, an concern absorption company, precocious published its third-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. The portfolio generated bully results successful the 3rd 4th and returned 6.78% compared to 8.12% for the S&P 500. YTD, the money returned 12.57% compared to 14.83% for the index. Additionally, you tin reappraisal the fund’s apical 5 holdings to spot its champion picks for 2025.

In its third-quarter 2025 capitalist letter, Giverny Capital Asset Management highlighted stocks specified arsenic Medpace Holdings, Inc. (NASDAQ:MEDP). Medpace Holdings, Inc. (NASDAQ:MEDP) is simply a objective research-based cause and aesculapian instrumentality improvement services provider. The one-month instrumentality of Medpace Holdings, Inc. (NASDAQ:MEDP) was -8.89%, and its shares gained 60.60% of their worth implicit the past 52 weeks. On December 08, 2025, Medpace Holdings, Inc. (NASDAQ:MEDP) banal closed astatine $549.17 per share, with a marketplace capitalization of $15.47billion.

Giverny Capital Asset Management stated the pursuing regarding Medpace Holdings, Inc. (NASDAQ:MEDP) successful its 3rd 4th 2025 capitalist letter:

"I'll springiness an illustration of wherefore I americium blessed to beryllium invested alongside these types of managers. Last year, we acquired shares successful Medpace Holdings, Inc. (NASDAQ:MEDP) astatine astir $381. Our partners successful Montreal owned Medpace and knew it well, and the much John Bleday and I studied the business, the much impressed we were. Medpace is simply a declaration probe enactment that does objective trials for aboriginal signifier biopharmaceutical companies. These are often start-ups with a promising cause compound that request assistance conducting trials connected hundreds of patients to show efficacy.